GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Net Margin %

SanBio Co (TSE:4592) Net Margin % : 0.00% (As of Jan. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. SanBio Co's Net Income for the three months ended in Jan. 2024 was 円-761.28 Mil. SanBio Co's Revenue for the three months ended in Jan. 2024 was 円0.00 Mil. Therefore, SanBio Co's net margin for the quarter that ended in Jan. 2024 was 0.00%.

The historical rank and industry rank for SanBio Co's Net Margin % or its related term are showing as below:


TSE:4592's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -151.78
* Ranked among companies with meaningful Net Margin % only.

SanBio Co Net Margin % Historical Data

The historical data trend for SanBio Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Net Margin % Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,153.27 - - - -

SanBio Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SanBio Co's Net Margin %

For the Biotechnology subindustry, SanBio Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where SanBio Co's Net Margin % falls into.



SanBio Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

SanBio Co's Net Margin for the fiscal year that ended in Jan. 2024 is calculated as

Net Margin=Net Income (A: Jan. 2024 )/Revenue (A: Jan. 2024 )
=-2644.332/0
= %

SanBio Co's Net Margin for the quarter that ended in Jan. 2024 is calculated as

Net Margin=Net Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-761.281/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SanBio Co  (TSE:4592) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


SanBio Co Net Margin % Related Terms

Thank you for viewing the detailed overview of SanBio Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co (TSE:4592) Business Description

Traded in Other Exchanges
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines